-
Uncategorized1 week agoRallyBio tries again for reverse merger, this time with Avenzo
It’s the second attempt for the rare disease company, which initially announced plans to merge with Candid Therapeutics before the immune drug developer was bought by...
-
Uncategorized1 week ago
Neuropixels Opto Integrates Electrophysiology and Optogenetics to Probe Neuronal Function
High-resolution extracellular electrophysiology is typically used to record from neurons in order to understand brain function. Combining electrophysiology with optogenetics allows researchers to test the causal...
-
Uncategorized1 week agoTurning the Patent Cliff into a Bioplant Opportunity
The 2030 patent cliff may either decimate revenue streams or provide an opportunity for innovation that can transform the biopharmaceutical industry. As it stands today, some...
-
Uncategorized2 weeks agoPharma’s Trial Problem: Outdated Systems, Broken Data, and the Coming AI Reset
Erik Terjesen Managing Director Silicon Foundry, a Kearney Company Clinical development has become the most resource-intensive stage of drug innovation. Across the industry, clinical trials consume...
-
Uncategorized2 weeks agoState of the Diagnostic Industry: Recombinants on the Rise
Discovery of a fragile foundation Four years ago in GEN, Scripps Laboratories predicted that the clinical diagnostic industry was on the verge of a recombinant protein...
-
Uncategorized2 weeks agoServier buys into muscular dystrophy with potentially $2.7B deal
The French drugmaker has agreed to acquire an experimental tablet from Edgewise Therapeutics that some bullish analysts say could eventually hit peak sales of over $2...
-
Uncategorized2 weeks ago
ASCO: A battle of bispecifics, Eli Lilly’s big win and more
Practice-changing data in lung cancer, prostate cancer and more were on display over the weekend at the American Society of Clinical Oncology annual meeting in Chicago....
-
Uncategorized2 weeks ago
17 companies expected to create 400+ Massachusetts jobs add under 50
Seventeen life sciences businesses awarded Massachusetts tax incentives to add and retain 426 combined jobs hit 10% of that target as of Dec. 31. Three companies,...
-
Uncategorized2 weeks ago
Servier frees Edgewise for cardio mission with $2.65B muscular dystrophy deal
Edgewise Therapeutics will now focus on a handful of cardiovascular programs including EDG-7500 for hypertrophic cardiomyopathy thanks to the non-dilutive capital from France’s Servier.
-
Uncategorized2 weeks agoNovel Therapeutic Modalities Target the Undruggable
From small molecules and protein therapeutics to gene therapies, biotech industry players have placed their bets on a wide range of modalities that push the limits...
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
